Company intelligence / Profile preview

Trimology Weight

United States

Ownership: Private
Development stage: Other

Overview

Trimology is a medical weight loss and telehealth company focused on providing personalized metabolic health solutions. The company facilitates access to GLP-1 receptor agonists, including semaglutide and tirzepatide, through a digital platform that connects patients with licensed healthcare providers. In addition to medication management, Trimology provides nutritional guidance and clinical monitoring to support sustainable weight loss. Their business model leverages a digital-first approach to streamline the treatment of obesity and related metabolic conditions. The company aims to improve affordability and accessibility for advanced weight management therapies through mail-order pharmacy partnerships.

Therapeutic areas: Metabolic DisordersEndocrinology
Modalities: PeptidesBiologic
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Trimology Weight.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trimology Weight.

Explore the full profile